Durect Corporation, has entered into a co-marketing and collaboration agreement with Charles River Laboratories, a global provider of drug discovery and non-clinical development solutions, for the ALZET Osmotic Pumps Portfolio and Associated Product Line in the U.S. and Canada.
 
The ALZET product line consists of miniature implantable pumps and a range of accessories for experimental research in mice, rats, and other laboratory animals. ALZET pumps continuously deliver drugs, hormones, and other test agents at controlled rates for durations ranging from 1 day to 6 weeks. They eliminate the need for external connections, frequent handling, or repeated dosing.
 
Charles River Research Models & Services (RMS) sales and marketing teams will collaborate with Durect to jointly market and commercialize the ALZET product line to existing and new customers in the pharmaceutical industry and academic laboratories over a multi-year period.
 
Charles River RMS will provide dedicated marketing resources and collaborate with Durect to develop and roll out a broad range of sales and marketing initiatives for ALZET. Durect will remain responsible for manufacturing, marketing support, order fulfillment and customer billing.
 
“The Durect and Charles River RMS teams are excited by this synergistic commercial partnership,” said James E. Brown, D.V.M., President and CEO of Durect. “Both teams look forward to collaborating to broaden awareness, promote and expand ALZET sales across the U.S. and Canada.”

Related News